- Home
- NOTE vs INMB Comparison
NOTE vs INMB Comparison
Compare NOTE & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- INMB
- Stock Information
- Founded
- NOTE 2013
- INMB 2015
- Country
- NOTE United States
- INMB United States
- Employees
- NOTE N/A
- INMB N/A
- Industry
- NOTE EDP Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- INMB Health Care
- Exchange
- NOTE Nasdaq
- INMB Nasdaq
- Market Cap
- NOTE 83.1M
- INMB 68.9M
- IPO Year
- NOTE N/A
- INMB 2019
- Fundamental
- Price
- NOTE $0.56
- INMB $2.56
- Analyst Decision
- NOTE Strong Buy
- INMB Buy
- Analyst Count
- NOTE 6
- INMB 4
- Target Price
- NOTE $2.63
- INMB $9.53
- AVG Volume (30 Days)
- NOTE 2.8M
- INMB 2.3M
- Earning Date
- NOTE 08-07-2025
- INMB 08-07-2025
- Dividend Yield
- NOTE N/A
- INMB N/A
- EPS Growth
- NOTE N/A
- INMB N/A
- EPS
- NOTE N/A
- INMB N/A
- Revenue
- NOTE $115,665,000.00
- INMB $50,000.00
- Revenue This Year
- NOTE N/A
- INMB $212.27
- Revenue Next Year
- NOTE $41.14
- INMB $10,184.28
- P/E Ratio
- NOTE N/A
- INMB N/A
- Revenue Growth
- NOTE N/A
- INMB N/A
- 52 Week Low
- NOTE $0.48
- INMB $1.89
- 52 Week High
- NOTE $2.03
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- NOTE 40.46
- INMB 38.43
- Support Level
- NOTE $0.54
- INMB $2.58
- Resistance Level
- NOTE $0.83
- INMB $3.24
- Average True Range (ATR)
- NOTE 0.08
- INMB 0.27
- MACD
- NOTE -0.02
- INMB 0.21
- Stochastic Oscillator
- NOTE 10.03
- INMB 43.19
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.